Skip to search.
 FTSE 100 Up 0.31%

More On BTGGF

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

BTG plc (BTGGF)

-Other OTC
8.21 0.00(0.00%) 18 Aug 19:39
Prev Close:8.21
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:0.577909
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:8.00 - 10.30
Volume:0
Avg Vol (3m):1,206
Market Cap:3.14b
P/E (ttm):40.25
EPS (ttm):0.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for BTGGF at this time.

Key Statistics

Forward P/E (1 yr):0.26
P/S (ttm):5.38
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Mar-17) :23.29
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):0.98

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals, and Licensing ... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback